pharma · Scabies · Bioequivalence trial in healthy volunteers
Alphapharm
Alphapharm Pty Ltd
Alphapharm Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Scabies, Bioequivalence trial in healthy volunteers, moderate to severely inflamed candidiasis of the skin, Mild to mod
Company details
- Status
- Public
- HQ
- Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
- Founded
- 1982
- Employees
- 187
- Programs
- 30
- Drugs
- 235
- Patents
- 12
CR6086-1-04
Phase 2 · small molecule · Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer, and other metastatic GI cancers
CR6086-1-04 for Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer, and other metastatic GI cancers is a Phase 2 program (small_molecule) at Alphapharm Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code CR6086-1-04
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alphapharm Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer, and other metastatic GI cancers
- Status
- active
- Trials
- 1